NEK2 and nasopharyngeal carcinoma: Our goal in this study is to identify NEK2 as a reliable, clinically useful prognostic marker through examining the effects of NEK2 overexpression on disease progression and drug resistance and exploring how high expression of NEK2 induces drug resistance in the NPC cells.